Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jan 10, 2023
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes of patients who have undergone arthroscopic rotator cuff repair (ARCR) surgery. Specifically, researchers want to see how well the tendons and muscles in the shoulder have healed over a period of 2 to 5 years after surgery. They will use a special ultrasound technique called shear-wave elastography (SWE) to measure the elasticity and strength of these tissues, comparing them to the healthy side of the shoulder.
To be eligible for this study, participants should have had ARCR surgery between 2015 and 2020 for specific types of rotator cuff tears. They should also be able to understand the study information and provide their consent. Participants can expect to undergo physical examinations and answer questions about their recovery. Remember, this trial is open to all genders and is currently recruiting participants aged 65 to 74. If you have had prior shoulder surgery, infections, or certain other conditions, you may not qualify for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • year of surgery between 2015 and 2020
- * ARCR surgery in cases of:
- • Partial or complete supraspinatus (SSP) tear
- • Partial or complete supraspinatus (ISP) tear
- • Partial or complete subscapularis (SSC) tear
- • Combined SSP, ISP and SSC tear
- • with or without biceps tenodesis during same procedure
- • able to understand the content of the patient information / consent form and give consent to take part in the study
- Exclusion Criteria:
- • revision surgery (prior repair of the rotator cuff in the same shoulder)
- • postoperative infections
- • patients with a language barrier hindering questionnaire completion (either in German, French, Italian or English)
- • legal incompetence
- • not eligible for Ultrasound (BMI \>35, persistent frozen shoulder)
- • Prior surgery or injury of the contralateral shoulder
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Andreas Müller, Prof. Dr. med.
Study Director
University Hospital Basel, Department of Orthopaedic and Trauma surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials